- Home
- BCTX vs DATS Comparison
BCTX vs DATS Comparison
Compare BCTX & DATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCTX
- DATS
- Stock Information
- Founded
- BCTX 2014
- DATS 2014
- Country
- BCTX Canada
- DATS United States
- Employees
- BCTX N/A
- DATS N/A
- Industry
- BCTX Biotechnology: Pharmaceutical Preparations
- DATS Computer Software: Prepackaged Software
- Sector
- BCTX Health Care
- DATS Technology
- Exchange
- BCTX Nasdaq
- DATS Nasdaq
- Market Cap
- BCTX 13.7M
- DATS 13.4M
- IPO Year
- BCTX N/A
- DATS 2021
- Fundamental
- Price
- BCTX $0.81
- DATS $2.60
- Analyst Decision
- BCTX Strong Buy
- DATS
- Analyst Count
- BCTX 1
- DATS 0
- Target Price
- BCTX $32.00
- DATS N/A
- AVG Volume (30 Days)
- BCTX 2.5M
- DATS 93.7K
- Earning Date
- BCTX 06-16-2025
- DATS 08-13-2025
- Dividend Yield
- BCTX N/A
- DATS N/A
- EPS Growth
- BCTX N/A
- DATS N/A
- EPS
- BCTX N/A
- DATS N/A
- Revenue
- BCTX N/A
- DATS $388.00
- Revenue This Year
- BCTX N/A
- DATS N/A
- Revenue Next Year
- BCTX N/A
- DATS N/A
- P/E Ratio
- BCTX N/A
- DATS N/A
- Revenue Growth
- BCTX N/A
- DATS N/A
- 52 Week Low
- BCTX $0.69
- DATS $1.11
- 52 Week High
- BCTX $29.40
- DATS $9.34
- Technical
- Relative Strength Index (RSI)
- BCTX 14.56
- DATS 47.09
- Support Level
- BCTX $0.69
- DATS $2.50
- Resistance Level
- BCTX $3.00
- DATS $2.74
- Average True Range (ATR)
- BCTX 0.20
- DATS 0.12
- MACD
- BCTX -0.15
- DATS -0.00
- Stochastic Oscillator
- BCTX 4.75
- DATS 24.61
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
About DATS DatChat Inc.
DatChat Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts.